PCSK9 and diabetes mellitus: Additional evidence from trials such as ODYSSEY DM-INSULIN and ODYSSEY DM-DYSLIPIDEMIA highlighted the efficacy of PCSK9 inhibitors in individuals with hypercholesterolemia and diabetes [131,132].